Paul Ginocchio - 13 Dec 2022 Form 4 Insider Report for Augmedix, Inc.

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Todd Holvick, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
13 Dec 2022
Net transactions value
+$21,600
Form type
4
Filing time
15 Dec 2022, 15:06:21 UTC
Previous filing
27 May 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Purchase $21,600 +18,000 +18% $1.20* 118,000 13 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $1.18 to $1.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.